Beth Mutai

Beth Mutai

Auto-generated profile, based on publicly available information

Beth Mutai

Kenya Medical Research Institute/US Army Medical Research Directorate–Africa/Kenya, Basic Science Laboratory. Off Kisumu - Kakamega Highway, Kisumu, Kenya

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2016 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
GKGathii Kimita
Gathii Kimita
BMBeth Mutai
Beth Mutai
SNSteven Nyanjom
Steven Nyanjom
FWFred Wamunyokoli
Fred Wamunyokoli
JWJohn Waitumbi
John Waitumbi
Rickettsia africae, the etiological agent of African tick bite fever, is widely distributed in sub-Saharan Africa. Contrary to reports of its homogeneity, a localized study in Asembo, Kenya recently reported high genetic diversity. The present study aims to elucidate the extent of this heterogeneity by examining archived Rickettsia africae DNA samples collected from different eco-regions of Kenya. To evaluate their phylogenetic relationships, archived genomic DNA obtained from 57 ticks a priori identified to contain R. africae by comparison to ompA, ompB and gltA genes was used to amplify five rickettsial genes i.e. gltA, ompA, ompB, 17kDa and sca4. The resulting amplicons were sequenced. Translated amino acid alignments were used to guide the nucleotide alignments. Single gene and concatenated alignments were used to infer phylogenetic relationships. Out of the 57 DNA samples, three were determined to be R. aeschlimanii and not R. africae. One sample turned out to be a novel rickettsiae and an interim name of “Candidatus Rickettsia moyalensis” is proposed. The bonafide R. africae formed two distinct clades. Clade I contained 9% of the samples and branched with the validated R. africae str ESF-5, while clade II (two samples) formed a distinct sub-lineage. This data supports the use of multiple genes for phylogenetic inferences. It is determined that, despite its recent emergence, the R. africae lineage is diverse. This data also provides evidence of a novel Rickettsia species, Candidatus Rickettsia moyalensis. Rickettsia africae is a bacterium mainly vectored by Amblyomma and Rhipicephalus species of ticks. It is the etiological agent of African tick bite fever (ATBF), a spotted fever rickettsiosis that presents as an acute febrile illness characterized by petecheal skin hemorrhages, from which the name is derived. This bacterium is probably the most important in sub-Saharan Africa, including Kenya, in terms of incidence and prevalence. This notwithstanding, the disease is poorly understood and is often mistreated as malaria, and therefore qualifies as a highly neglected disease. This study examined the genetic relationships of R. africae collected from diverse eco-regions of Kenya. We present data that indicate high genetic diversity in Kenya’s R. africae and corroborate a recent study that reported similar genetic diversity in R. africae samples collected from a localized area in western Kenya. Importantly, we describe a divergent lineage and propose the name Candidatus Rickettsia moyalensis.

17 August 2022 in Communications Medicine
Verified
Journal Article
Open access
PDF file
GKGathii Kimita
Gathii Kimita
JNJosphat Nyataya
Josphat Nyataya
EOEsther Omuseni
Esther Omuseni
FSFaith Sigei
Faith Sigei
ALAlan Lemtudo
Alan Lemtudo
JWJohn Waitumbi
John Waitumbi
Background: Kenya’s COVID-19 epidemic was seeded early in March 2020 and did not peak until early August 2020 (wave 1), late-November 2020 (wave 2), mid-April 2021 (wave 3), late August 2021 (wave 4), and mid-January 2022 (wave 5). Methods: Here, we present SARS-CoV-2 lineages associated with the five waves through analysis of 1034 genomes, which included 237 non-variants of concern and 797 variants of concern (VOC) that had increased transmissibility, disease severity or vaccine resistance. Results: In total 40 lineages were identified. The early European lineages (B.1 and B.1.1) were the first to be seeded. The B.1 lineage continued to expand and remained dominant, accounting for 60% (72/120) and 57% (45/79) in waves 1 and 2 respectively. Waves three, four and five respectively were dominated by VOCs that were distributed as follows: Alpha 58.5% (166/285), Delta 92.4% (327/354), Omicron 95.4% (188/197) and Beta at 4.2% (12/284) during wave 3 and 0.3% (1/354) during wave 4. Phylogenetic analysis suggests multiple introductions of variants from outside Kenya, more so during the first, third, fourth and fifth waves, as well as subsequent lineage diversification. Conclusions: The data highlights the importance of genome surveillance in determining circulating variants to aid interpretation of phenotypes such as transmissibility, virulence and/or resistance to therapeutics/vaccines.

18 October 2021 in Research Square
Verified
Preprint
Open access
PDF file
GKGathii Kimita
Gathii Kimita
JNJosphat Nyataya
Josphat Nyataya
EOEsther Omuseni
Esther Omuseni
FSFaith Sigei
Faith Sigei
ALAllan Lemtudo
Allan Lemtudo
JWJohn Waitumbi
John Waitumbi
Kenya’s COVID-19 epidemic was slow to peak. It was seeded early in March 2020, and did not peak until late-July 2020 (wave 1), mid-November 2020 (wave 2) and late-March 2021 (wave 3). Here we present SARS-CoV-2 lineages associated with the three COVID-19 waves through analysis of 483 genomes, which included 167 Alpha (B.1.1.7), 57 Delta (B.1.617.2) and 12 Beta (B.1.351) variants of concerns (VOC) that dominated the third wave. In total, 35 lineages were identified. The early European lineages B.1 and B.1.1 were the first to be seeded in Kenya. The B.1 lineage continued to expand and remained the most dominant lineage accounting for 55.8% and 56.3% in waves 1 and 2 respectively. The alpha (B.1.1.7), delta (B.1.167.2) and beta (B.1.351) VOCs dominated in wave 3 at 59.0%, 20.1% and 4.2% respectively. Eventually, the delta variant took over at the tail end of wave 3 and at the time of going to press, it had become the major lineage in the whole country. Phylogenetic analysis suggested multiple introductions of variants from outside Kenya especially during the first and third wave. Phylogeny also highlighted local lineage diversification as local transmission events supervened. The data highlights the importance of genome surveillance in determining circulating variants to aid in public health interventions.

21 July 2022 in African Journal of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
JWJohn Waitumbi
John Waitumbi
EOEsther Omuseni
Esther Omuseni
JNJosphat Nyataya
Josphat Nyataya
CMClement Masakhwe
Clement Masakhwe
FSFaith Sigei
Faith Sigei
BMBeth Mutai
Beth Mutai
Background: The Basic Science Laboratory (BSL) of the Kenya Medical Research Institute/Walter Reed Project in Kisumu, Kenya addressed mass testing challenges posed by the emergent coronavirus disease 2019 (COVID-19) in an environment of global supply shortages. Before COVID-19, the BSL had adequate resources for disease surveillance and was therefore designated as one of the testing centres for COVID-19. Intervention: By April 2020, the BSL had developed stringent safety procedures for receiving and mass testing potentially infectious nasal specimens. To accommodate increased demand, BSL personnel worked in units: nucleic acid extraction, polymerase chain reaction, and data and quality assurance checks. The BSL adopted procedures for tracking sample integrity and minimising cross-contamination. Lessons learnt: Between May 2020 and January 2022, the BSL tested 63 542 samples, of which 5375 (8.59%) were positive for COVID-19; 1034 genomes were generated by whole genome sequencing and deposited in the Global Initiative on Sharing All Influenza Data database to aid global tracking of viral lineages. At the height of the pandemic (August and November 2020, April and August 2021 and January 2022), the BSL was testing more than 500 samples daily, compared to 150 per month prior to COVID-19. An important lesson from the COVID-19 pandemic was the discovery of untapped resilience within BSL personnel that allowed adaptability when the situation demanded. Strict safety procedures and quality management that are often difficult to maintain became routine. Recommendations: A fundamental lesson to embrace is that there is no ‘one-size-fits-all’ approach and adaptability is the key to success.